Although this observation is limited to a single case, it supports the hypothesis that, although uncommonly, subclonal ESR1 mutations may occur in ET-naive HR+ HER2- BC specimens, and they may expand ET-induced selective evolutive pressure. Here, ESR1 is linked to breast cancer.